UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies

PloS one, 2018-10, Vol.13 (10), p.e0205135-e0205135

2018

Volltextzugriff (PDF)

CD38-bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B-cell malignancies

Blood, 2018-02, Vol.131 (6), p.611-620

2018

Volltextzugriff (PDF)

Oxidation of p-[125I]Iodobenzoic Acid and p-[211At]Astatobenzoic Acid Derivatives and Evaluation In Vivo

International journal of molecular sciences, 2022-09, Vol.23 (18), p.10655

2022

Volltextzugriff (PDF)

Glypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinoma

Scientific reports, 2021-02, Vol.11 (1), p.3731-3731, Article 3731

2021

Volltextzugriff (PDF)

Development of [211At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignancies

Leukemia, 2022-06, Vol.36 (6), p.1485-1491

2022

Volltextzugriff (PDF)

Small-scale (sub-organ and cellular level) alpha-particle dosimetry methods using an iQID digital autoradiography imaging system

Scientific reports, 2022-10, Vol.12 (1), p.17934-17934, Article 17934

2022

Volltextzugriff (PDF)

Investigation of a tellurium-packed column for isolation of astatine-211 from irradiated bismuth targets and demonstration of a semi-automated system

Scientific reports, 2019-11, Vol.9 (1), p.16960-7, Article 16960

2019

Volltextzugriff (PDF)

Development of an autonomous solvent extraction system to isolate astatine-211 from dissolved cyclotron bombarded bismuth targets

Scientific reports, 2019-12, Vol.9 (1), p.20318-14, Article 20318

2019

Volltextzugriff (PDF)

Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (14), p.3885-3893

2017

Volltextzugriff (PDF)

Enigmatic astatine

Nature chemistry, 2013-03, Vol.5 (3), p.246-246

Wilbur, D Scott

2013

Volltextzugriff (PDF)

Chemical and radiochemical considerations in radiolabeling with α-emitting radionuclides

Current radiopharmaceuticals, 2011-07, Vol.4 (3), p.214-247

Wilbur, D Scott

2011

Volltextzugriff (PDF)

Pilot study of humanized glypican-3-targeted zirconium-89 immuno-positron emission tomography for hepatocellular carcinoma

EJNMMI research, 2024-08, Vol.14 (1), p.74-9

2024

Volltextzugriff (PDF)

An automated flow system incorporating in-line acid dissolution of bismuth metal from a cyclotron irradiated target assembly for use in the isolation of astatine-211

Applied radiation and isotopes, 2017-04, Vol.122 (C), p.202-210

2017

Volltextzugriff (PDF)

Glypican-3 targeted positron emission tomography detects sub-centimeter tumors in a xenograft model of hepatocellular carcinoma

EJNMMI research, 2023-04, Vol.13 (1), p.35-35, Article 35

2023

Volltextzugriff (PDF)

Harnessing α -Emitting Radionuclides for Therapy: Radiolabeling Method Review

Journal of Nuclear Medicine, 2022-01, Vol.63 (1), p.5-13

2022

Volltextzugriff (PDF)

Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma

Clinical cancer research, 2011-12, Vol.17 (23), p.7373-7382

2011

Volltextzugriff (PDF)

Radiochemical aspects of alpha emitting radionuclides for medical application

Radiochimica acta, 2019-09, Vol.107 (9-11), p.1065-1085

2019

Volltextzugriff (PDF)

Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model

Blood, 2011-07, Vol.118 (3), p.703-711

2011

Volltextzugriff (PDF)

A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations

Blood, 2009-05, Vol.113 (20), p.4903-4913

2009

Volltextzugriff (PDF)

Evaluation of a Wet Chemistry Method for Isolation of Cyclotron Produced [211At]Astatine

Applied sciences, 2013-09, Vol.3 (3), p.636-655

2013

Volltextzugriff (PDF)

In vivo localization of ⁹⁰Y and ¹⁷⁷Lu radioimmunoconjugates using Cerenkov luminescence imaging in a disseminated murine leukemia model

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (20), p.5846-5854

2014

Volltextzugriff (PDF)

Radiobromine and radioiodine for medical applications

Radiochimica acta, 2019-09, Vol.107 (9-11), p.1033-1063

2019

Volltextzugriff (PDF)

A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts

Blood, 2001-10, Vol.98 (8), p.2535-2543

2001

Volltextzugriff (PDF)

211 At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation

Journal of Nuclear Medicine, 2024-09, Vol.65 (9), p.1443-1449

2024

Volltextzugriff (PDF)

Radiohalogens for imaging and therapy

Chemical Society reviews, 2005-02, Vol.34 (2), p.153-163

2005

Volltextzugriff (PDF)

1 – 25 von 316

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(298)
Mit Volltextzugriff
(287)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(316)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies

CD38-bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B-cell malignancies

Oxidation of p-[125I]Iodobenzoic Acid and p-[211At]Astatobenzoic Acid Derivatives and Evaluation In Vivo

Glypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinoma

Development of [211At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignancies

Small-scale (sub-organ and cellular level) alpha-particle dosimetry methods using an iQID digital autoradiography imaging system

Investigation of a tellurium-packed column for isolation of astatine-211 from irradiated bismuth targets and demonstration of a semi-automated system

Development of an autonomous solvent extraction system to isolate astatine-211 from dissolved cyclotron bombarded bismuth targets

Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas

Enigmatic astatine

Chemical and radiochemical considerations in radiolabeling with α-emitting radionuclides

Pilot study of humanized glypican-3-targeted zirconium-89 immuno-positron emission tomography for hepatocellular carcinoma

An automated flow system incorporating in-line acid dissolution of bismuth metal from a cyclotron irradiated target assembly for use in the isolation of astatine-211

Glypican-3 targeted positron emission tomography detects sub-centimeter tumors in a xenograft model of hepatocellular carcinoma

Harnessing α -Emitting Radionuclides for Therapy: Radiolabeling Method Review

Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma

Radiochemical aspects of alpha emitting radionuclides for medical application

Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model

A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations

Evaluation of a Wet Chemistry Method for Isolation of Cyclotron Produced [211At]Astatine

In vivo localization of ⁹⁰Y and ¹⁷⁷Lu radioimmunoconjugates using Cerenkov luminescence imaging in a disseminated murine leukemia model

Radiobromine and radioiodine for medical applications

A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts

211 At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation

Radiohalogens for imaging and therapy

Suchergebnisse filtern